Navigation Links
Cell Therapeutics, Inc. (CTI) BIO CEO Presentation to be Webcast
Date:2/9/2009

SEATTLE, Feb. 9 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management's presentation at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10th at 9:30 AM Eastern will be webcast live with slides at http://www.celltherapeutics.com.

The presentation will take place in the Jade Room at the Waldorf-Astoria Hotel, and will also be available for replay after the presentation.

                        BIO CEO & Investor Conference
                 CTI Presentation: Tuesday, February 10, 2009
           9:30 AM Eastern/3:30 PM Central European/6:30 AM Pacific
                       Jade Room, Waldorf-Astoria Hotel
         Audio webcast with slides athttp://www.celltherapeutics.com

     Media Contact:
     Cell Therapeutics, Inc.
     Dan Eramian
     T: 206.272.4343
     F: 206.272.4434
     E: media@ctiseattle.com
    http://www.celltherapeutics.com/press_room

     Investors Contact:
     Cell Therapeutics, Inc.
     Ed Bell
     T: 206.272.4345
     Lindsey Jesch Logan
     T: 206.272.4347
     F: 206.272.4434
     E: invest@ctiseattle.com
    http://www.celltherapeutics.com/investors

'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients
2. Cell Therapeutics, Inc. (CTI) to Present at 11th Annual BIO CEO & Investor Conference
3. Cell Therapeutics, Inc. Provides Update on the Special Meeting of Shareholders
4. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes
5. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
6. Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides
7. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
8. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7
9. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
10. Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
11. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-...alottoCapitalInc.,aleadingproviderofadvancedlasers...lityclinicmarkets,todayreportedoperationalandfinan.... , ,Q32009Highlights,-Revenuewas$1.46millioncom...s66.3percentcomparedwith66.1percentinQ3,2008,-Netl...
(Date:11/24/2009)..., BOZEN,Italy,November24/PRNewswire/--HealthRoboti...enturewithagroupofselected,investors.Thisrecentlyf...ealthRoboticsCanada,Inc.andwillmarket,install,ands...hichincludesthe,revolutionaryproductofferingsi.v.S...CanadaInc.willalsoprovideassistanceonan"asneeded,b...
(Date:11/23/2009)...T LAKE CITY, Nov. 23, 2009 In a provocative new s...ising carbon dioxide emissions the major cause of...orld,s economy collapses or society builds the equ..., "It looks unlikely that there will be any subs... acceleration in carbon dioxide emission rates," s...
(Date:11/23/2009)..., INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCall/...cedthatNASDAQhasestablishedNovember27,2009astheex-...kholdersresultingfromthesecuritizationtransactionc...cember15,2009toallstockholdersofrecordontherecordd...areamountofthedividendat$1.67pershareofcommonstock...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
... Multiporator , , , , , , ... Protocol , Protocol No. 4308 915.030 ... , , , , , , ... epitheloid carcinoma, , , ...FP-N1 (in bidistilled H 2 O), , ...
... Multiporator , , , , , , ... Protocol , Protocol No. 4308 915.033 ... , , , , , , ...ma T-cell line, , , ...in bidistilled H 2 O), , , ...
... Multiporator / Electroporator 2510 , , ,... Transformation Protocol , Pr... , , , , , , , ,... Escherichia coli C600, , ... gram negative, , , ...
Other Biology Technology:HeLa 2EL 4 2Escherichia coli C600 2Escherichia coli C600 3
(Date:11/24/2009)...November 24, 2009) -- The Wildlife Conservation So...t the last remaining population of Siberian tigers...ng tide of poaching and habitat loss. , ...fficials of what needs to be done to protect remai... The report was released by the Siberia...
(Date:11/24/2009)...4, 2009) New research on bacterial communities th... predictable temporal patterns, suggesting that sc...r monitoring climate change in the polar regions. ... of the National Academy of Sciences Early Editio...ers shifted synchronously over time, correlating w...
(Date:11/23/2009)...unity-associated strain of the deadly superbug MRS...ommon antibioticsposes a far greater health threat...hospitals, according to a study in the December is...w threat is easily picked up in fitness centers, s...the overall burden of MRSA within hospitals, the r...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu China 14557 1China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu China 14557 2Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 1Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 2Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 3Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 4Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 5Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 6Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 7Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 8Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 9Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 10Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 11Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 12Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 13Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 14Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 15Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 16Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 17Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 18Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 19Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 20Lilly Reports Solid Third Quarter 2009 Results 3B Revises Full Year 2009 EPS Guidance 5632 21CT scans better than X rays when detecting abnormalities in patients with H1N1 virus 59888 1
...m the University of Turin, Italy and the Universit... method that may help the medical community to det...Their findings are described in an article publish...utational Biology. , Thousands of human diseases...entification of mutated genes is a crucial first s...
...Y, March 27, 2008 -Sustaining hope in the face of ...c lateral sclerosis (ALS) should be a goal of pall...a continuum from focusing on the self to concern f...e April issue (Volume 8, Number 3) of Journal of P...eer-reviewed publication of Mary Ann Liebert, Inc ...
... armed beetle is proving that size doesnt necessar...eatures pulling techniques will be revealed in the... Ecological Entomology journal. , In the world of...often fight for mating rights and those with the l...s is not always the case with one particular speci...
Other Biology News:Hope among patients with ALS may take a variety of forms 2
Rat Big Endothelin-1 (Big ET-1) EIA Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-Qa-1 (L-12) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat TIMP-1 ELISA Kit from R&D Systems
Mouse Anti-Mouse Qa-1 Monoclonal Antibody, Unconjugated, Clone 6A8.6F10 from Santa Cruz Biotechnology, Inc.
Biology Products: